文献速递肝病消化道肿瘤与早癌消化内镜

令牌引导的多模态预后框架:以肿瘤-间质比指导肝细胞癌预后评估

Token-guided multimodal prognosis in hepatocellular carcinoma: a framework steered by tumour-stroma ratio.
PubMed 文献 · Gut · 2026-03-18

本研究基于回顾性队列(n=392)和TCGA数据集(n=168),探讨肿瘤-间质比(TSR)与肝细胞癌(HCC)死亡率的非线性关系,并开发AI驱动的多模态预后框架。结果显示TSR与死亡率呈倒U型非线性关系,风险起始阈值为0.188,峰值为0.268。AI衍生的TSR与专家评估高度相关(R²>0.9),多模态框架的预后AUC>0.80,优于单模态基线。

要点

  • TSR与HCC死亡率呈倒U型非线性关系,风险起始阈值0.188,峰值0.268。
  • AI衍生的TSR与专家评估高度相关(R²>0.9)。
  • 令牌引导的多模态融合框架预后AUC>0.80,优于单模态基线。

核心结论

  • TSR与HCC死亡率呈倒U型非线性关系,高风险表型以肿瘤增殖、间质激活和微环境串话为特征。
  • 令牌引导的多模态融合框架整合WSI、TSR和临床变量,预后准确性优于单模态基线。

研究设计与样本

  • 回顾性队列(n=392)与TCGA数据集(n=168)整合全切片图像和临床变量。
  • 采用限制性立方样条分析非线性风险动态,并通过转录组学和免疫组化进行生物学验证。
  • 开发AI驱动的基础模型框架用于TSR量化和多模态预后建模。

主要发现

  • TSR与死亡率呈倒U型非线性关系,风险起始阈值为0.188,峰值为0.268。
  • 高风险表型转录组学特征为活跃的肿瘤增殖、间质激活和肿瘤微环境串话。
  • AI衍生TSR与专家评估强相关(R²>0.9)。
  • 多模态框架预后AUC>0.80,优于单模态基线。

临床怎么用

  • 建议采用AI驱动的TSR量化替代手动评估,以提高标准化和可重复性。
  • 可利用令牌引导的多模态融合框架整合WSI、TSR和临床变量进行HCC预后预测。
  • 关注TSR非线性风险阈值(0.188起始,0.268峰值)以识别高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The tumour-stroma ratio (TSR) is a potential prognostic indicator, yet hindered by quantification challenges and conflicting reports. OBJECTIVE: To determine whether TSR follows a non-linear prognostic pattern and to develop an artificial intelligence (AI)-powered framework for standardised TSR assessment and prognosis prediction in hepatocellular carcinoma (HCC). DESIGN: We integrated whole-slide image (WSI) data with clinical variables across a retrospective cohort (n=392) and The Cancer Genome Atlas dataset (n=168). Restricted cubic splines were used to interrogate non-linear hazard dynamics, with biological validation via transcriptomics and immunohistochemistry. An AI-driven foundation model framework was developed for TSR quantification and multimodal prognostic modelling. RESULTS: Our analysis unveiled an inverted U-shaped non-linear relationship between TSR and mortality, identifying a risk initiation threshold at 0.188 and a peak at 0.268. Transcriptomics analysis indicated that this high-risk phenotype is characterised by active tumour proliferation, stromal activation and tumour microenvironment crosstalk. Technically, AI-derived TSR showed strong correlation with expert assessment (R² >0.9). Furthermore, we developed a novel 'Token-Guided Multimodal Fusion' architecture to integrate WSI, TSR and clinical variables as high-dimensional tokens directly into the computational logic. Consequently, our multimodal framework demonstrated prognostic accuracy (area under the curve >0.80) compared with unimodal baselines. CONCLUSION: This study redefines TSR assessment, shifting from manual estimation to high-dimensional semantic reasoning. By identifying the non-linear prognostic mechanics of the stroma, our token-guided framework offers a biologically interpretable solution for HCC. We suggest that the future of computational pathology may lie not in simple quantification, but in the semantic fusion of human domain knowledge with AI reasoning.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Huang HY, Wu K, Qu LM, et al. Token-guided multimodal prognosis in hepatocellular carcinoma: a framework steered by tumour-stroma ratio. Gut. 2026. PMID: 41850702. doi:10.1136/gutjnl-2025-337945

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。